About
The first report on the use of hCG for the management of obesity was published in 1954 by the late Dr. ATW Simeons, a British Physician practicing at the Ospedale Salvatori Mundi in Rome.
Working in India, he noticed that the so-called “fat boys,” who showed Adiposogenital dystrophy improved their undescended testis when they were treated with hCG. But he also observed that body fat distribution modified during the treatment course. Therefore he hypothesized that if those children were concomitantly submitted to a very Hypo caloric diet they could reduce their body weight, consuming the “fat on the move”.
What Is hCG?
Human chorionic gonadotropin or Human chorionic gonadotrophin (hCG) is a glycoprotein hormone produced in pregnancy that is made by the developing embryo soon after conception and later by the syncytiotrophoblast. Its role is to prevent the disintegration of the corpus luteum of the ovary and thereby maintain progesterone production that is critical for a pregnancy in humans. hCG may have additional functions; for instance, it is thought that hCG affects the immune tolerance of the pregnancy. Early pregnancy testing, in general, is based on the detection or measurement of hCG. Because hCG is produced also by some kinds of tumor, hCG is an important tumor marker, but it is not known whether this production is a contributing cause or an effect of tumorigenesis.
